Literature DB >> 17167860

Serosurvey of human metapneumovirus infection in Croatia.

Suncanica Ljubin Sternak1, Tatjana Vilibić Cavlek, Ann R Falsey, Edward E Walsh, Gordana Mlinarić Galinović.   

Abstract

AIM: To assess the seroprevalence of human metapneumovirus (hMPV) in Croatia.
METHODS: During 2005, a total of 137 serum specimens from Croatian patients aged from 6 days to 51 years, without respiratory symptoms, were collected at the Croatian National Institute of Public Health. The sera were examined using the indirect immunofluorescent assay.
RESULTS: The overall hMPV seropositivity rate in the samples tested was 77.4% (106/137). The seropositivity rate increased from 18.7% in children aged between 6 months and 1 year to 100% in people older than 20 years of age. The highest proportion of titers > or =1:512 was found in children aged from 1 to 2 years.
CONCLUSION: Our results suggest that hMPV infection is present in Croatia, with primary infection occurring in early childhood. This is the first study that indicates the circulation of hMPV in Croatia.

Entities:  

Mesh:

Year:  2006        PMID: 17167860      PMCID: PMC2080490     

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  10 in total

1.  Serologic evidence of human metapneumovirus circulation in Uruguay.

Authors:  Santiago Mirazo; Dora Ruchansky; Andrea Blanc; Juan Arbiza
Journal:  Mem Inst Oswaldo Cruz       Date:  2006-01-09       Impact factor: 2.743

2.  Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups.

Authors:  Guy Boivin; Yacine Abed; Gilles Pelletier; Louisette Ruel; Danielle Moisan; Stéphanie Côté; Teresa C T Peret; Dean D Erdman; Larry J Anderson
Journal:  J Infect Dis       Date:  2002-10-08       Impact factor: 5.226

3.  Human metapneumovirus infections in young and elderly adults.

Authors:  Ann R Falsey; Dean Erdman; Larry J Anderson; Edward E Walsh
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

4.  High seroprevalence of human metapneumovirus among young children in Israel.

Authors:  Dana G Wolf; Zichria Zakay-Rones; Ayman Fadeela; David Greenberg; Ron Dagan
Journal:  J Infect Dis       Date:  2003-12-05       Impact factor: 5.226

5.  Presence of the new human metapneumovirus in French children with bronchiolitis.

Authors:  François Freymouth; Astrid Vabret; Loic Legrand; Nicolas Eterradossi; Françoise Lafay-Delaire; Jacques Brouard; Bernard Guillois
Journal:  Pediatr Infect Dis J       Date:  2003-01       Impact factor: 2.129

6.  Seroprevalence of human metapneumovirus in Japan.

Authors:  Takashi Ebihara; Rika Endo; Hideaki Kikuta; Nobuhisa Ishiguro; Mikio Yoshioka; Xiaoming Ma; Kunihiko Kobayashi
Journal:  J Med Virol       Date:  2003-06       Impact factor: 2.327

7.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors:  B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

8.  Antigenic and genetic variability of human metapneumoviruses.

Authors:  Bernadette G van den Hoogen; Sander Herfst; Leo Sprong; Patricia A Cane; Eduardo Forleo-Neto; Rik L de Swart; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

9.  Human metapneumovirus infections in hospitalized children.

Authors:  Guy Boivin; Gaston De Serres; Stéphanie Côté; Rodica Gilca; Yacine Abed; Louis Rochette; Michel G Bergeron; Pierre Déry
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

10.  Human metapneumovirus: a new player among respiratory viruses.

Authors:  Marie-Eve Hamelin; Yacine Abed; Guy Boivin
Journal:  Clin Infect Dis       Date:  2004-03-15       Impact factor: 9.079

  10 in total
  6 in total

Review 1.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 2.  SELECTED EPIDEMICS & EMERGING PATHOGENS.

Authors:  Robin B McFee
Journal:  Dis Mon       Date:  2017-09-12       Impact factor: 3.800

Review 3.  SELECTED EPIDEMICS & EMERGING PATHOGENS - RESPIRATORY ILLNESSES - AN OVERVIEW.

Authors: 
Journal:  Dis Mon       Date:  2017-09-12       Impact factor: 3.800

Review 4.  Global infections--avian influenza and other significant emerging pathogens: an overview.

Authors:  Robin B McFee
Journal:  Dis Mon       Date:  2007-07       Impact factor: 3.800

Review 5.  Antiviral therapy for respiratory tract infections.

Authors:  Samson S Y Wong; Kwok-Yung Yuen
Journal:  Respirology       Date:  2008-11       Impact factor: 6.424

6.  A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life.

Authors:  Marie-Louise von Linstow; Mette Høgh; Svein Arne Nordbø; Jesper Eugen-Olsen; Anders Koch; Birthe Høgh
Journal:  Eur J Pediatr       Date:  2008-01-03       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.